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Abstract 
Background: Prisoners report much higher prevalence rates of drug use and more harmful consumption patterns 
than the general population. People who use drugs have above‑average experiences with the criminal justice system 
in general, and the prison system and subsequent release situations in particular. Release from prison is associated 
with increased mortality rates among drug users due to the risk of overdose. The EU‑funded project ‘My first 48 hours 
out’ aimed to address the gaps in continuity of care for long‑term drug users in prison and upon release, with a spe‑
cial focus on drug user’s perspectives on needs and challenges upon release.
Methods: A multi‑country (Belgium, France, Germany and Portugal) qualitative study was set up to explore drug 
users’ perceptions of drug use and risk behaviour upon prison release, experiences of incarceration and release, and 
strategies to avoid risks when being released. In total, 104 prisoners and recently released persons with a history of 
drug use participated in semi‑structured interviews and focus groups discussions on these topics.
Results: Respondents pointed out that there are numerous challenges for people who use drugs when released 
from prison. Lack of stable housing and employment support were frequently mentioned, as well as complex admin‑
istrative procedures regarding access to services, health insurance and welfare benefits. Besides structural challenges, 
individual issues may challenge social reintegration like ‘old habits’, mental health problems and disrupted social 
networks. As a result, (ex‑)prisoners adopt individual strategies to cope with the risks and challenges at release.
Conclusion: Measures to prepare prisoners for release often do not focus on the individual and specific challenges 
of persons who use drugs. Psychosocial and medical support need to be improved and adjusted to drug users’ needs 
inside and outside prison. To improve the quality and continuity of care around release, the perspectives and coping 
strategies of people who use drugs should be used to better address their needs and barriers to treatment.
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Background
Prisoners report much higher prevalence rates of drug 
use and more harmful consumption patterns than the 
general population [1]. Lifetime prevalence among 
prisoners in the European Union for using any illicit 
substance before imprisonment is estimated between 
16% (Romania) and 79% (England, Wales and the Neth-
erlands), and between 15% (Finland) and 39% (Spain) for 
using heroin [2]. Up to 37.8% of all prisoners declared to 
have injected drugs at some point in their lives; while up 
to 31% stated to have injected drugs during imprison-
ment [2]. Although drug use as such is not a criminal 
offence in most European countries, most regular opioid 
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users report multiple experiences with the prison system. 
As a result, people who use drugs have above-average 
contacts with the criminal justice system in general, and 
the prison system and subsequent release situations in 
particular [3].
Release from prison is associated with increased mor-
tality rates among drug users due to the high risk of 
overdose [4–10]. Sixty per cent of all drug-related deaths 
occur within 12 weeks after release from prison [8] and 
20% of drug-related deaths are connected with prison 
release or leaving treatment [11]. In England and Wales, 
released female prisoners were 69 times more likely to die 
of drug-related causes during the first week after release, 
while released male prisoners were 28 times more likely 
to decease than people from the general population of 
the same age and gender [4]. In particular, the immedi-
ate period after release is a critical period for support 
and action, when cooperation between health and social 
services in prison and the community is the key factor to 
ensuring continuity of care (throughcare) [12–14]. Tar-
geted interventions can save lives and build pathways 
towards engagement in further treatment and recovery 
[15], but coordination and continuity of care need to be 
improved in many countries [16]. Preparing prisoners 
for release starts inside prison and needs to be contin-
ued after release, without interruption of health care and 
social support. Anecdotal evidence shows this is not the 
case in most countries due to a patchy network of ser-
vices and ad hoc provision of support at the level of single 
prison establishments, resulting in enormous differences 
between regions and countries around Europe [17]. For 
example, measures that focus on overdose prevention at 
prison release have only been reported in 15 out of 33 
countries in the EU [11].
The multi-country research project ‘My first 48 hours 
out—comprehensive approaches to pre-and post-prison 
release interventions for drug users in the criminal jus-
tice system’ (2017–2019) was funded by the European 
Commission (CHAFEA Grant Nr: 677085) to address 
gaps in the continuity of care for long-term drug users in 
prison and upon release. The project aimed at promoting 
life-saving interventions for the prevention of overdose, 
reducing risks related to drug use and establishing recov-
ery pathways that are not interrupted upon release [18]. 
This paper focuses in particular on the perceived con-
tinuity of care as experienced by drug users who are/
were imprisoned and on their perspectives of challenges 
associated with release and strategies applied to initiate/
maintain recovery beyond the prison walls.
Methods
A multi-country (Belgium, France, Germany and Portu-
gal) qualitative study was set up to explore drug users’ 
perceptions of drug use and risk behaviour upon release 
from prison, their experiences of incarceration and 
release, knowledge of risks and overdose prevention, 
and individual risk reduction mechanisms and strate-
gies they apply when being released. The choice of these 
four countries was primarily based on previous success-
ful collaboration in a project on access to harm reduction 
measures in prison and on the diversity in harm reduc-
tion and health care policies in prisons in these countries, 
representing practices from the West, Center and South 
of Europe [19]. Some notable differences between these 
countries in the organisation of prison health care for 
persons who use drugs are mentioned in Table 1. Impor-
tantly, the possession (for personal use) of all drugs was 
decriminalised in Portugal in 2001, which may have led 
to slight differences in the profile of (formerly) incarcer-
ated Portuguese drug users as compared with those in 
the other countries.
Sample
The study sample consisted of 104 respondents (Table 2). 
Individual interviews (n = 84) were administered 
among 43 prisoners and 41 former prisoners, includ-
ing 12 women and 72 men. In addition, 5 focus groups 
were organised in prisons, with in total 20 participants 
(5 women and 15 men). Female prisoners appeared to 
be more difficult to reach because they are underrepre-
sented in the prison system compared to males and not 
all prisons have facilities for women. Female respondents 
Table 1 Differences between the countries regarding health care and drug treatment before/during/after prison
Topic Germany France Belgium Portugal
Cost free access to OST? (in community) Yes Yes No Yes
Access to Naloxone? (in community) Yes (limited) Yes No No
Responsibility for care organization? (inside prison) Ministry of Justice Ministry of Justice Ministry of Justice Ministry of Health
OST available in prison? (inside prison) Not in all Yes Yes Yes
Take home naloxone available? (inside prison) No Yes No No
Certificate providing access to health insurance? (at release) No Yes Yes Not needed
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were only recruited in France and Germany. The average 
age of participants was 36.7 years (range 19 to 54 years). 
Participating prisoners and ex-prisoners had served on 
average 5.3 detention periods (range 1–35) and spent—
on average—a total of 86.4  months in prison (range 
1–336  months). Former prisoners had been released 
from prison for an average of 2.2 months at the time of 
the interview. The primary drugs used by most respond-
ents were cocaine and heroin, often in combination with 
other substances like crack, amphetamines, ecstasy and/
or cannabis.
Data collection
The research took place between May 2017 and August 
2018 in six prisons in the four participating countries 
(two in Germany, two in Belgium, one in France and one 
in Portugal) and in several services that support people 
who use drugs (in prison), e.g. inpatient and outpatient 
drug treatment centres, low-threshold services, opioid 
substitution programs in the community, prison health 
and social services.
Prisoners were recruited through prison staff after the 
researchers received authorisation for the interviews 
in prisons. While the researchers in Belgium had direct 
access to prisoners to inform them about the study, the 
researchers in France, Portugal and Germany had to 
rely on professionals inside prison to approach eligible 
interviewees. In order to be eligible for the study, prison-
ers had to meet the following criteria: (1) being a recent 
and/or regular user of illicit drugs (other than cannabis), 
(2) having served at least one prior prison sentence, (3) 
master the country language sufficiently to do an inter-
view, and (4) be willing and available to participate in 
an interview. Recruitment strategies differed between 
the four countries according to the specific context and 
policy, but the eligibility criteria and methodological 
approach were the same, in order to allow a comparative 
analysis.
In all cases, eligible participants were informed in 
various ways about the project (e.g. through personal 
contacts, flyers) and participation was completely vol-
untary. In case individuals were interested, they signed 
an informed consent form and the interview could take 
place immediately or at a fixed moment in a dedicated 
place without the presence of staff, video or any other 
control measure.
Former prisoners were recruited through treatment 
and harm reduction services in the community. These 
organisations were approached via email, telephone and 
personal contacts to help with the recruitment of recently 
released prisoners (up to five months maximum). In 
some cases, flyers were distributed in these organisations, 
so that ex-prisoners could contact the researcher or the 
organisation’s social workers if they wished to participate 
in the study. Former prisoners were eligible if they (1) had 
served at least one prison sentence (the last one maxi-
mum of five months ago), (2) were recent and/or regu-
lar users of illegal drugs (other than cannabis), (3) spoke 
enough Dutch, German, French or Portuguese to partici-
pate in the interview (according to the primary language 
in each of the participating countries), and (4) were will-
ing and available to participate in the study.
All interviewees participated voluntarily based on 
an informed consent and could stop the interview at 
any time. In all cases, the informed consent form was 
explained before the start of the interview. Potential 
Table 2 Number of prisoners and ex‑prisoners participating in each country in interviews and focus groups
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participants were informed that there was no obligation 
to answer all questions. If the person agreed with the 
content of the informed consent, he/she could sign the 
form and the interview could start. Nearly all interviews 
were recorded using an audio recorder. Afterwards, the 
interviews were transcribed and anonymised. Only in 
Portugal some interviews were not recorded, since there 
was no authorisation to do so in prison. In these specific 
cases, the interviews were directly documented by the 
interviewer. Following the end of the interview or focus 
group discussion, participants received a small incentive 
(10 EUR) in the form of cash, a gift voucher or tobacco 
for participating in the study.
Prisoners and former prisoners were interviewed using 
a semi-structured interview. In addition to the inter-
views, focus groups were organised in three countries to 
make authentic utterances more likely during the shared 
interaction and to allow the course of the discussion to 
point to topics that are important to the group. The fol-
lowing topics were discussed: drug use and risk behav-
ior in prison and upon release, knowledge of the risks of 
overdose and methods to deal with overdose, individual 
strategies to deal with drug use, and related risks and 
experiences with release. Both methods can be regarded 
complementary and the interviews were used to assess 
individuals’ perspectives and to obtain information about 
individual strategies and statements, while the focus 
group discussion were organized to stimulate discus-
sion around these themes and to better contextualize the 
study findings. The topic lists used for the semi-struc-
tured interviews and focus groups were translated from 
English into the country language and were identical in 
the four countries.
Data‑analysis
Based on a first content analysis of the interviews and 
focus groups, a common tree structure was developed 
for structuring the data analysis in all four countries. 
The themes and subthemes were selected in close col-
laboration between the researchers from all four coun-
tries. Data-analysis was performed using the qualitative 
software program NVivo, by assigning meaningful text 
segments (nodes) to the tree structure. Perspectives and 
experiences of (ex-)prisoners that were collected during 
interviews and focus groups were analysed thematically 
in each country and then merged into one common ana-
lytic framework.
Country-specific results are discussed in separate 
country reports and were not considered for this paper, 
as the researchers in the four countries found very simi-
lar results and identified the same core themes during 
the analysis. In order to illustrate the results, we use lit-
eral quotations from the semi-structured interviews: 
quotations from prisoners are marked with the abbre-
viation PR, while quotations by former prisoners are 
marked as EPR. In addition, M/F indicates whether a 
man or woman mentioned this quotation. The country 
of the respondent was abbreviated as BE for Belgium, FR 
for France, DE for Germany and PT for Portugal. To pre-




Respondents make clear that it is very difficult to return 
to the rush of present-day society and to get ‘up to date’ 
with the latest developments, especially during the first 
days and weeks after release. The longer one has served 
a sentence, the more difficult this is. It feels like an enor-
mous confrontation with the speed and time pressure in 
society, which is a huge contrast with the ‘structure and 
order’ in prison, where nothing seems to change. Accord-
ing to the respondents, handling the first days outside 
is very hard and some have the feeling that they have to 
learn again how to live and to organise their daily new 
routine, especially how to behave in interaction with oth-
ers in society.
“(…) At the same time it is confusing. We are closed 
in here for so long that it seems that we no longer 
belong to this world” (PR, M, PT)
A lot of things are expected immediately after release, 
like administrative settlings, making contacts with peo-
ple in society and managing a life outside prison. In 
this regard, some respondents indicate a lack of internal 
motivation to contact services and engage in activities, or 
that they are struggling to accept support.
One of the main coping strategies upon release is to 
cling to old habits (‘automatic reflexes’), in order to deal 
with the transition, which often meant returning to 
their previous activities and environments, such as drug 
use, friends who use drugs, or criminal involvement. 
Respondents state that returning to former social net-
works, when they mainly consist of persons involved in 
drug trafficking and dealing, is mostly a result of a diffi-
cult period after/upon release.
“According to me, the big challenge is to reconnect 
with people. Again, it depends. If the person has 
done three months, that’s fine. But for people who 
have done more than a year, (…), it is not easy to 
return […].The stress, the cars driving, all the noise,.., 
all that stuff is kind of stressful. The person may be 
inclined to consume just to calm down.” (EPR, M, 
FR).
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The family and social network can also impact the 
release experience in a negative way. Negative emotional 
experiences towards family or friends who do not want 
to meet them after release, fear of stigmatisation by their 
social networks and a lack of social support are reported 
as negative experiences upon release. The absence of 
close relatives or their reactions may lead to strong 
disillusion.
“Upon the last release, I had to see my family who 
was supposed to pick me up. They didn’t pick me up, 
and it didn’t go well. I had emotional expectations, 
I thought I’d see them, they didn’t come. (…) At this 
moment, I was out of my mind. So what did I do? I 
started using again. I didn’t go to my treatment cen-
tre, so I was on the run and I eventually came back 
here [in prison].” (PR, M, FR).
The interviews show that the main fear of prisoners is 
a relapse after release, because some respondents antici-
pate that they will not have the power to address the dif-
ficulties and challenges upon release successfully.
In addition to challenges at individual level, structural 
bottlenecks may further complicate individuals’ reinte-
gration after release from prison. Housing and employ-
ment are major challenges for most respondents. Having 
sources of support in the community (like drug treatment 
services, friends and family) is seen as very helpful in 
terms of financial/logistic support, as well as for provid-
ing shelter and social and emotional support. Arranging 
paperwork is another major challenge in the first days 
after release. Obtaining a health insurance and access 
to OST appear to be particularly difficult. Respondents 
also mention the mental harm after a prison sentence, 
and sometimes the wish to go back to prison. The lack of 
coordination and attunement between medical and psy-
chosocial support inside and outside prison is reported in 
all countries.
Despite the importance of adequate housing, some 
respondents indicated that they lost their flat during 
detention and did not know where to go after release. 
Often participants had no proper housing solution, even 
though housing was one of their main concerns. Some 
struggled to find emergency accommodation in a shelter 
and others were forced to sleep rough. Others managed 
to arrange accommodation in a low-threshold service or 
in a treatment centre specifically designed for ex-prison-
ers with a history of drug use (like in France). A few par-
ticipants obtained private accommodation, which gave 
them a sort of confidence and protection.
“I want to treat myself, I want to feel good so I can 
go on with my life properly. What I need is to feel it, 
to have a comfort zone. In prison, I have a comfort 
zone, I don’t need to worry. Being at home with my 
parents, I might not need to worry, I would feel use-
ful and gradually, I think I would take my life back.” 
(PR, M, FR).
Another major challenge upon release is finding a 
job and/or training/education. Respondents indicate 
that it is very hard to find employment outside prison 
when you have a criminal record. Employment is often 
regarded an important aspect of reintegration because 
it provides a daily structure, allows to perform a task in 
the community and provides financial resources.
“After imprisonment, the biggest difficulty I 
encounter is the financial situation and employ-
ment.” (PR, M, PT)
The complexity of administrative procedures is also 
frequently criticized by interviewees. To obtain basic 
requirements and support such as identity documents, 
health insurance and welfare benefits, it is necessary 
to have a stable life routine and a good understanding 
of the administrative system. Respondents often had 
to start these procedures from zero: without a fixed 
address, bank account or proof of ID. Therefore, this 
often laborious task is regarded a seemingly impossible, 
which brings about disappointment or frustration.
Various respondents described the huge gap between 
the support they received inside prison and the support 
they got once out of prison. They experienced a difficult 
transition from relatively accessible, regular and well-
defined support inside prison to a more volatile and 
sporadic support in the community. It appears as if care 
inside prison was somehow ‘passively’ received, while 
health care outside prison requires much more motiva-
tion, persistence and action. A treatment gap regarding 
opioid substitution treatment illustrates this problem: 
in prison, users are called into the medical unit for their 
medication each day, and a strict routine is installed, 
but once they are released they need to find a way to 
obtain OST without health insurance, and sometimes 
without prescription. In some countries, health services 
in prison provide medication for two or three days on 
the day of release, but respondents didn’t find this was 
enough to make the bridge between prison support and 
community treatment.
“The problem is that I only had for two days of 
methadone on me and since I had to go to X [an 
addiction treatment centre]at the third day, not 
having treatment anymore […] could be compli-
cated. So, the evening before, I took half of the med-
ication and saved the other half for the morning. 
But it’s true that in the evening, I wasn’t very well 
and I went back to my neighbourhood. I smoked a 
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little heroin to remove the craving. It wasn’t really 
a desire I would have had if I had had all my treat-
ment, but that’s the way it went down.” (EPR, M, 
FR).
A frequently heard negative story at release is that pris-
oners are released unexpectedly, especially in case of a 
short prison sentence. Since the release date is not known 
in advance, prisoners often end up on the street all of a 
sudden. Respondents in all countries also reported that 
they got no support at this point and were ‘kicked out’ 
of prison only with a bag and no plan to go. Some indi-
cate that they would rather have stayed inside than to be 
released without a plan.
The majority of respondents indicate that prepara-
tions for release are often minimal. Most (ex-) prison-
ers felt uncomfortable on the day of release due to the 
uncertainty about not knowing what situation they would 
face afterwards. Some state that they lost their flat dur-
ing imprisonment or found their flat in bad condition 
after release. In some cases, respondents reported that 
they were released on a Friday and that they had to wait 
until the next weekday for continuing their OST. Most 
respondents indicated that they went or would go to 
shelter homes or low-threshold drug treatment centres 
upon release, which are associated with drug use, dirt 
and unhelpful contacts. However, they mostly found a 
place to sleep at these places and reported useful contacts 
with social workers and the possibility of accessing OST.
Respondents indicate that if a prisoner serves a short 
sentence or chooses to serve the whole sentence (with-
out being released early through provisional or condi-
tional release), usually no reintegration plan is made up 
with the prisoner. In case of a longer sentence, prisoners 
are entitled to parole and exit permissions before release, 
which facilitates making arrangements. They can work on 
a rehabilitation plan: searching for a house, doing paper-
work, looking for a job and restoring ties with the family 
are things that can already be picked up before release.
Reasons to use drugs at release
Most participants recall having used drugs in the two 
weeks following their last release. Using drugs at release 
can be considered as a strategy to cope with the uncer-
tainty and stress caused by the fact that their release was 
not well prepared.
Respondents point out the difference between the 
mindset they had before release and the one they had 
after consuming drugs again: even when they are con-
vinced they will stick to the treatment and not use again, 
they gradually make one concession after the other and 
they very quickly find themselves in the same situa-
tion as before their incarceration. Some ‘experienced’ 
respondents mention an evolution between the first 
releases from prison and subsequent ones: when they 
were younger, they felt the need to ‘party’ for two or 
three days after release to compensate as quickly as pos-
sible for the deprivation they endured during detention. 
Later, they tend to be more careful about it and resist this 
urge because the switch to regular use could happen very 
quickly. (Ex-)Prisoners indicate that boredom and being 
without housing are important pitfalls to start using 
again or to continue using after release.
“First of all, a roof above your head, because for 
99.9 per cent there is a chance that… Who wants to 
live on the street? As a drug addict you will relapse, 
because they cannot cope with that and [will use] for 
feeling better, even though it’s the wrong thing to do 
[…], feeling stronger at the moment.” (EPR, F, DE).
The importance of a daily schedule and having some-
thing to do (a job, hobbies) is often quoted by partici-
pants. A pitfall for relapse is having contact with the (old) 
user network. Often, there is no other (drug-free) net-
work on which they can rely the days following release. 
Respondents’ networks often include people who use 
drugs and are thus seen as acting as a stimulus to use 
again. Persons who returned to their old neighbour-
hood to seek social contact and support feared that they 
would run into friends who are still using drugs. Shelters 
providing emergency accommodation also increase the 
chance of meeting people who use drugs and are consid-
ered by the participants as a risk factor for relapsing into 
drug use. Also, when one is lonely and without (social) 
support at that moment, the step towards drug use is eas-
ily made.
“I was released and I wanted to pick up again the 
outpatient drug treatment I had before detention, 
but my therapist was on leave. So, I wanted to work 
on it for three weeks, but I couldn’t and then I lost 
control. I had a relapse. I met an old friend who 
was still using speed and […]. Last time, I was free 
again and I did everything well: I requested financial 
support and got two weeks of support. But the third 
week, they told me I had to find my own way. I went 
back to my brother and used drugs, I shouldn’t have 
done that. But it is difficult if you are in that circuit. 
Certainly, if your brother is a user, most of my fam-
ily are users … Where can I go? You’re in the middle 
of a struggle… You come out, have no home, I could 
stay with my brother, but I was also alone there, so 
what do you do to be able to talk to someone? I went 
to my cousin, but he also used drugs there. I lost 
myself. I thought I could handle it, but first it is one 
line [of coke], another line half an hour later and like 
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this you’re back again on drugs.” (PR, M, BE).
Participants pointed out that lack of activities imme-
diately following release is an additional risk factor for 
drug use. Even when health support or administrative 
procedures were initiated, they report long periods of 
waiting for social or medical support to be able to move 
forward. During this post-release period, they often lack 
a sustainable housing solution and cannot seek employ-
ment as their administrative situation is not regulated 
yet. Given this uncertain situation and difficult transi-
tion, having nothing to do contributes to anxiety and/or 
disorientation.
Some interviewees indicate that they had a very strong 
motivation inside prison, but felt substantial craving after 
release. Also being ‘clean’ (especially after no access to 
OST inside (e.g. in Germany)) can be an important pit-
fall for using drugs outside, as a number of respondents 
stressed the ‘need’ for drugs or a ‘good cocktail’ (combi-
nation of cocaine and heroin) after release. In some cases, 
increased consumption is reported after release, others 
use less than before imprisonment.
“And these thoughts you had what to do after 
release: work, new life, looking for a flat and this and 
that. All this just disappears on the day of release. 
You’ll forget that soon after you leave the prison a 
few yards away. That’s so bad. That is madness. And 
then, again and again drugs.” (EPR, M, DE).
“But sometimes, when you didn’t use drugs for a long 
time, there is also craving. Then you have to satisfy 
the addiction. Yes, and that’s a real force to do this 
sometimes.” (PR, M, DE).
Difficulties that (ex-) prisoners encounter when arrang-
ing things like employment and housing are not helpful 
either and may trigger them to use again. Moreover, a 
number of respondents indicates that if medical treat-
ment is not continued after release (because of lack of 
health insurance), relapse is very likely.
“If you have a lot of money at release and no doc-
tor anymore [for prescribing OST], so what do you 
do first? You think: “Yes, OK. I’m just getting the bare 
necessities, so I’m not on withdrawal.” And what do I 
do then? That does not last that long.” (EPR, M, DE).
Individual strategies to cope with risks associated 
with drug use
The interviews showed that respondents apply spe-
cific, individual strategies to cope with risks associated 
with drug use. These coping strategies exist at individ-
ual level, but some strategies are mentioned by several 
respondents.
Some (ex-) prisoners indicate that it was helpful to 
change their lives. Changes in social life (daily structure, 
work, leisure time), contacts (friends, dealers) and hous-
ing were reported as being particularly helpful for chang-
ing drug use patterns. This strategy is also applied and 
experienced as helpful in the community: (ex-) prisoners 
break up contacts with drug users and stay away from 
their old neighbourhoods. Having (new) clean contacts is 
definitely thought to be helpful. Some also report a need 
to know more about their personal risk factors for drug 
use, while some indicated that a realistic perspective is 
helpful (with abstinence not being possible for them).
“Hand on heart, I cannot do it without a substitute. 
What’s so reprehensible to say is: I cannot do it. 
That’s it, and I live with it legally and I can live with 
it. I can also build a life for me with a substitute. 
And that’s what I recognised and not thought: what 
do others think? I do not care what others think. 
That’s my life.” (PR, F, DE).
Some (ex-) prisoners state that they intentionally avoid 
visits from some people in prison (e.g. friends) to protect 
themselves from having drugs being brought in. Another 
strategy to stay away from drugs in prison is having 
something to do. Participating in organised activities 
such as fitness, sports or cooking helps prisoners to relax, 
reduce stress and distract their thoughts. According to 
several respondents, having a structure (with daily tasks 
and activities) is also very helpful in the outside world.
“I want to change my life for myself, so I stay away 
from the people who are still using drugs here.” (PR, 
F, DE)
According to several respondents, having a person 
of trust and/or children is of great help outside prison. 
Carefully preparing for someone’s release is seen as a 
necessary condition. Several prisoners indicate that 
someone is lost when arrangements are only made upon 
release. Moreover, (ex-) prisoners state that it is impor-
tant to find a way to cope with the prison period and to 
recover from the stress they experienced in prison.
“They [fears of overdose after release] really exist 
and I thought so too, because I’m scared, but the only 
thing that helps me is that I do not consume when I 
go to my children. I know that I will not consume, 
because when my children are there, their presence 
always makes me forget everything else.” (PR, F, DE).
In specific cases, (ex-)prisoners apply strategies like 
setting small goals for themselves, regular abstinence 
periods, or organising finances and administrative tasks 
before taking drugs after release.
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Individual harm reduction strategies are named regard-
ing overdose prevention. Respondents indicate that it 
is common sense not to use too much or to take overly 
large dosages. A proven strategy is to stick to a certain 
dose. Another respondent states that you should only 
use one third of the normal dose, if you haven’t used for 
a long time. It is recommended to build up consumption 
gradually, first by using a little bit and then a little more 
later, to reduce the risk of overdose. Another strategy is 
to use a different mode of administering drugs immedi-
ately after release, such as smoking instead of injecting.
“To use the drug in moderation. If I want to eat eve-
rything at once, I’m bound to go down. After using, 
wait a bit.” (PR, M, PT)
“If I use drugs, I do me half (of the usual dosage) or 
less than half and then I wait. What happens when 
I realise, oh, there is something wrong? Then I stop.” 
(EPR, M, DE)
Several (ex-)prisoners mention that is important to 
‘know the drugs that you are using’. A proven strategy 
reported in Belgium [only available outside prison] is to 
have the drugs tested first to know about purity and qual-
ity. An overdose can also be prevented by never using 
alone or using in a consumption room, where someone 
else can help you if necessary. In Portugal, respondents 
specifically argue for the provision of safe drug consump-
tion sites as a structural measure to prevent overdose.
“Knowing what you are using. Many years ago, I 
have seen people injecting and dying. They do not 
know, they think they are injecting cocaine and it is 
not cocaine. They do not really know what they are 
using.” (PR, M, PT).
“Take less. … and always with another person, that 
one is there. […] That’s the first, if you go away (use) 
alone and you do not know the stuff.” (EPR, M, DE)
Some respondents mentioned emergency measures in 
case of an overdose like using salt water or naloxone.
“I’ve seen a person with such a problem. The boy who 
was injecting stood there and never got up again. The 
other who was smoking took salt water and stuck it 
in and he woke up. I also know that naloxone pre-
vents it.” (PR, M, PT).
Finally, abstinence was also reported by some partici-
pants as the best way to prevent an overdose.
Positive and helpful measures at release
Most respondents had more negative than positive feel-
ings regarding release, except Portuguese respondents. 
Having a home and good contacts with family and friends 
are obvious positive factors associated with release. 
Having ‘someone who waits’ in the community helped 
them to ‘keep their mind off drugs’ and was reported as 
being very helpful and supportive in the period immedi-
ately following release. Respondents note that a support-
ive social network is the main factor in enabling positive 
reintegration, since they are the ones caring for their 
needs at release, namely social support, housing, supplies 
and finances. However, the majority of the respondents 
from this sample did not have such a prosocial network.
“I came to the conclusion that family is very impor-
tant for any type of rehabilitation or reintegration, 
because they support such basic things as food or 
housing.” (PR, M, PT)
Some respondents associate release with a sense of 
freedom.
“The moment of departure is a unique moment, so 
much joy that no matter how angry you are you for-
get everything. I missed things when I was in prison. 
When you walk out the door, you have access to fam-
ily, the most beloved ones. (…) The door being open is 
all good.” (PR, M, PT).
At structural level, respondents reported diverse expe-
riences. The majority of respondents mentioned bad 
experiences, but some also had good ones. Besides hous-
ing, the major protective factor appears to be finding a 
job after release. Work is associated with strong and 
multiple support, since it is linked with reinsertion, an 
income, social contact, and, most of all, an occupation. 
One of the ex-prisoners even presents work as a way to 
‘find exhaustion at night’, and to get back to a normal 
‘rhythm’ in his life.
Regarding access to health care, some participants con-
vey positive experiences of coordination of care between 
professionals outside and inside prison, allowing them to 
feel more secure just before and after release. Some men-
tioned the leave they obtained from the prison adminis-
tration to prepare their release and to visit a residential 
treatment centre for a day. A methadone prescription 
provided before release by the prison medical service 
and/or treatment centres providing free OST or OST for 
persons who pay themselves were mentioned as highly 
practical and reassuring by the interviewees, as receiving 
OST is one of the major challenges upon release if indi-
viduals have no health insurance.
Some respondents refer to specific education and 
trainings inside as a positive element for reintegration, 
including receiving information and identifying interests 
for leisure activities in the community. Besides training, 
some respondents mention that residential therapeutic 
programs have a positive effect after release, in terms of 
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the opportunity to meet other people who recovered and 
are leading their own life autonomously.
“(…) There, I worked with medical therapists, did 
small community work and then would move to 
live in an autonomous reinsertion home. I felt it 
was important, I met people who recovered and 
went there at weekends to talk about what they had 
already achieved.” (PR, M, PT).
Some (ex-) prisoners mention the positive impact of 
preparation for release. This is often related to follow-
ing therapy after release or specific support like a social 
worker outside, case or transition management or the 
support of family and friends. Only a few respondents 
report that they experienced an open prison regime, but 
found it very helpful for learning to live outside.
Discussion
This multi-country, qualitative study among 104 prison-
ers and ex-prisoners who use drugs demonstrates that 
respondents are facing similar specific challenges at the 
point of release from prison in Belgium, France, Ger-
many and Portugal. As a consequence of these substantial 
needs, they start to adopt strategies to cope with these 
individual and structural challenges, in particular when 
their release is not well prepared by prison and com-
munity services. Continuity of support [12], linkage to 
community services [20] and specific prevention meas-
ures [14] (e.g. provision of take-home naloxone kits) are 
crucial elements for reducing the number of drug-related 
deaths and promoting social reintegration after release. 
The conclusions and recommendations drawn from this 
study fill an important gap, as they are based on the rich 
experiences of long-term drug users. Although study par-
ticipants may be regarded quite old and using ‘traditional’ 
drugs (i.e. heroin and cocaine) compared to newer gen-
erations of persons who use drugs, all respondents had 
experienced multiple detention periods and subsequent 
releases. They can be considered ‘system survivors’ as 
they have experienced specific challenges and learnt to 
cope with these difficulties on their own, in the absence 
of sufficient support. Consequently, their experiences 
and perspectives are an important source of information 
to develop more appropriate harm reduction and social 
reintegration strategies [21].
Individual (e.g. stress, unrealistic expectations, social 
network support) and structural (e.g. housing, employ-
ment, administrative burden) challenges and barriers 
affect drug use in prison and after release substantially. 
Throughcare, a UK approach to improve continuity of 
medical and psychosocial care before, during and after 
imprisonment, reduces the risks of relapse and overdose 
at release [22]. The provision of throughcare and other 
models of individual case management is important to 
reduce drug use [23] and to increase the likelihood of re-
integration after release [12, 24], especially for prisoners 
with multiple health and psychosocial needs. The find-
ings from this study clearly show the complex and mul-
tiple needs of drug users in prisons across various EU 
countries, in particular at the point of release, but meas-
ures and services to prepare their reintegration are scarce 
and mostly limited to prisoners who serve long-term 
sentences. Drug treatment and medical care are impor-
tant helping resources for persons who use drugs, besides 
addressing complex psychosocial needs like housing, 
social support and a day structure [3, 10, 25].
Respondents perceived the continuity of opioid sub-
stitution treatment (OST) as having a positive effect on 
the reduction of drug use and risks related to drug use in 
prison and upon release. On the other hand, (ex-)prison-
ers identified that discontinuity of OST or receiving lower 
dosages as a risk factor for drug use in prison or directly 
after release. Available studies and guidelines show that 
medically assisted treatment with OST can reduce the 
risks of relapse and overdose at release and should be a 
core element of health care services for prisoners who 
use opioids [5, 10, 26–28]. All countries that participated 
in this study provide OST in prison, although dosage and 
coverage rates differ between countries but also between 
regions and prisons within these countries [19].
Since several respondents mentioned to have experi-
enced an overdose, the provision of naloxone is—besides 
providing OST—an important measure to prevent drug-
related deaths due to overdose [5]. Naloxone is an opioid 
antagonist capable of reversing an opioid overdose due 
to opioids, such as heroin or prescription opioid drugs. 
Naloxone has been available on prescription for at-risk 
drug users and their family/friends since 1999 through 
selected programmes around the world [29]. Some coun-
tries have adopted Naloxone as a core strategy in reduc-
ing overdose deaths like Scotland, where naloxone is an 
integral part of overdose prevention at release [30, 31]. A 
recent study clearly shows that providing drug users with 
take-home naloxone at release can reduce the number of 
overdose deaths after release [32]. Based on this study, 
it appears that only prisons in France provide naloxone 
kits and training for overdose prevention before release. 
Prisoners in the other participating countries had no 
legal access to naloxone. Despite promising experi-
ences reported in Scotland and other parts of the world 
[31], this strategy of mortality prophylaxis appears to be 
widely neglected. As the findings of this study indicated, 
most persons who inject drugs know about the risks of 
overdose but also need more information to manage 
overdose situations [33].
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The perspectives of the respondents that were inter-
viewed in Belgium, France, Germany and Portugal clearly 
showed that psychosocial support is regarded as a crucial 
element to prevent drug use and relapse upon release. 
While medical care can be provided to all drug users in 
a rather standardized way, psychosocial support needs to 
be tailor-made taking into account individuals’ specific 
needs or situations. Preparation for release (including 
family, financial, housing and employment issues) as part 
of a throughcare or continuing care approach can be a 
key factor to successful reintegration [10, 22]. Challenges 
at release appear to be rather complex [34, 35], includ-
ing more individual stressors and triggers and structural 
elements that may hamper successful reintegration and 
recovery. On a structural level, respondents emphasized 
the importance of decent housing, which is often not 
available and urges ex-prisoners to look for shelter in low 
threshold centres or with friends where they may be chal-
lenged to use again. Finding a job or training and regulat-
ing administrative issues are other important challenges 
for ex-prisoners, which were identified in all countries. 
On a more individual level, a lack of daily routine, stress 
and lack of prosocial (non-drug using) social networks 
were mentioned as critical elements at release. Protective 
factors that were named by respondents included starting 
with or continuing treatment after release, the availabil-
ity of special resources in the community such as a case 
manager or social worker outside or support from family 
or friends [5]. Successful linkage to community resources 
(e.g. therapeutic programs or training centres) is consid-
ered crucial for attending these services after release [20, 
24]. Moreover, the reduction of boredom, stress and lone-
liness is anticipated to have a positive effect on drug use. 
Also, respondents state that providing meaningful activi-
ties like offering a daily routine, occupation or work or 
the organisation of workshops helps to do so. Ultimately, 
the findings of this study demonstrate that individual, 
tailor-made preparation for release is crucial for prison-
ers who use drugs to cope with the challenges which may 
lead to relapse and overdose at release. Most (ex-) pris-
oners the sample had experienced more than one prison 
release. This is shown in their ideas of their own individ-
ual challenges and in their individual strategies to cope 
with the risks at release, which they developed. Individual 
strategies focus on risk behaviour regarding drug use and 
overdose as well on challenges upon release. Even though 
they pointed out that social support (social worker, fam-
ily, friends) is the most important strategy.
Policy implications
In most of the prisons that were studied, generic meas-
ures to prepare prisoners for release do exist, although 
these do not take into account the specific and individual 
challenges of people who use drugs and are primarily tar-
geted at prisoners serving long sentences. Medical and 
psychosocial support needs to be improved and adjusted 
to their needs inside and outside prison [19]. To imple-
ment ameliorated harm reduction and social reintegra-
tion measures, it is important to learn from the individual 
needs and strategies of people who use drugs as apparent 
from this study and to clearly illustrate specific needs as 
identified across the participating countries.
Drug use, related risk behaviour and overdose risks 
needs to be discussed with prisoners who use drugs/
with a history of drug use before release. Prevention 
programmes, especially inside prison, need to improve 
knowledge and support among prisoners to cope with 
factors that lead to drug use in prison or relapse/overdose 
upon release [14]. The experience of ‘experts by experi-
ence’ and peers who use drugs should also be used in 
prison settings to develop and implement more effective 
prevention and harm reduction strategies. In order to do 
so, a range of services and initiatives can be introduced:
• Realistic information, education and communication 
(IEC) strategies about the risks of relapse after release 
(in particular peer-based interventions)
• Improved connections between health and social 
services provided inside as well as outside prison
• Continuity of medication-assisted treatment (e.g. 
OST) for opioid-dependent prisoners
• (Re-)uptake of medication-assisted treatment for opi-
oid-dependent prisoners before release (approx. six 
months) to reduce the risk of relapse
• Training on overdose management and provision of 
naloxone kits before release [5, 30].
In addition, measures at individual level may help to 
prevent relapse upon release. The availability of and sup-
port by a prosocial social network is definitely a protec-
tive factor that needs to be prepared for prior to release 
[5]. Also, measures and regulations that allow prison-
ers to prepare their release (e.g. by visiting a commu-
nity treatment program, looking for housing) contribute 
to their social reintegration. Professional and informal 
support initiatives should in particular focus on the pre-
release period and the days/weeks immediately following 
release, but it is recommended to extend re-entry sup-
port services up to 12 months post-release [5].
At structural level, more efforts are needed to sim-
plify administrative procedures regarding reintegration 
(e.g. for arranging welfare or unemployment benefits, 
Page 11 of 12Jamin et al. Harm Reduct J           (2021) 18:32  
housing, continuing OST without disruption). Health 
care reintegration appeared to be particularly challeng-
ing in Germany and France, while the Portuguese sys-
tem of providing free access to usual treatment without 
delay can be inspiring for other countries. Other meas-
ures that may promote reintegration are the provision 
and continuity of psychosocial support [12], transi-
tional housing or supported housing initiatives for drug 
user after release, specific drug treatment initiatives 
addressing the challenges at release from prison and 
better cooperation between prison-based and commu-
nity-based social and health services. Ideally, persons 
who use drugs should be diverted as much as possible 
from the criminal justice system [5].
Limitations of the study
Although we were able to recruit a sample of over 
100 prisoners and ex-prisoners for this multi-method 
study, all countries faced several difficulties in engaging 
respondents due to the slow and hierarchical organisa-
tion of prison systems. In Germany, researchers expe-
rienced problems in getting access to prisons due to 
the involvement of different ministries of justice, while 
in France the research team did not receive authorisa-
tion for doing focus groups with prisoners. Despite 
providing a financial compensation for study participa-
tion, it was not evident to recruit many prisoners who 
wanted to talk openly about their drug use and release 
experiences. It appeared particularly difficult to engage 
ex-prisoners in some countries, as they make use of a 
variety of services and sometimes do not want to be 
reminded of their prison stay (or do not reveal their 
status to support workers out of fear for stigma and 
discrimination). Despite these challenges, we managed 
to conduct at least 15 semi-structured interviews per 
country with (ex-)prisoners who recently used drugs 
and had previous release experiences.
One of the main limitations of the study is that the 
sample is not very diverse. For practical reasons, we 
only included Dutch-, German-; French- and Portu-
guese-speaking participants, while the prison popula-
tion is much more diverse in most countries. Also, we 
limited recruitment to a number of prisons per coun-
try (two in Germany and Belgium, one in France and 
Portugal). Also, only a few community services par-
ticipated in each country for recruiting ex-prisoners. 
Contact persons in prisons and community services 
helped to select respondents, except in Belgium and 
Portugal, where the researchers could approach poten-
tial respondents directly. It cannot be ruled out that 
there was some degree of selection by these gatekeep-
ers. Female prisoners could only be included in the 
German branch of the study. Finally, the sample of ex-
prisoners may be biased by the fact that only individu-
als who were in contact with some type of community 
services were recruited for this study. It is possible that 
released prisoners with a drug use history who were not 
involved in any of these services or who were involved 
in different types of services may have other experi-
ences regarding release.
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